IFNB1 and asthma: A randomized, controlled trial with a 14-day regimen of inhaled IFN-β therapy following the onset of cold symptoms in asthma patients suggested that inhaled IFN-β could be beneficial in controlling virus-induced asthma exacerbations in severe asthmatics, although the trial did not meet its primary endpoint [158].